8-K

Company

Decoy Therapeutics Inc.

Filed

January 2, 2026

Period of Report

December 31, 2025

Accession Number

0001615219-26-000005

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →